Literature DB >> 3688301

Seminal vesicle involvement by in situ and invasive transitional cell carcinoma of the bladder.

J Y Ro1, A G Ayala, A el-Naggar, K I Wishnow.   

Abstract

We report six cases of seminal vesicle involvement by transitional cell carcinoma of the bladder among 187 consecutive cystoprostatectomy specimens. Two of these six cases showed mucosal spread without stromal invasion (type A); the remaining four cases presented a direct extension (type B) from muscle-invasive carcinomas of the bladder. Type A involvement of the seminal vesicle was associated with a long history of superficial bladder cancer with similar mucosal spread to the prostatic ducts, acini, and ejaculatory ducts. One type A case showed extensive pagetoid spread of transitional cell carcinoma to the urethral meatus and collecting ducts of the kidney. Because the clinical significance of mucosal spread or direct invasion of seminal vesicles is not clear, pathologists and urologists need to be aware of these phenomena. More cases should be analyzed to determine further clinicopathologic implications.

Entities:  

Mesh:

Year:  1987        PMID: 3688301     DOI: 10.1097/00000478-198712000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  3 in total

1.  Seminal vesicle involvement by urothelial carcinoma in situ of the bladder with mucosal spread pattern: a case report.

Authors:  Song-Yi Choi; Ho-Chang Lee; Hyung Geun Song; Wun-Jae Kim; Ok-Jun Lee
Journal:  Korean J Urol       Date:  2012-05-18

2.  [Urothelial carcinoma in situ of the seminal vesicles--an indicator of tumour multifocality].

Authors:  N T Gaisa; A Donner; S von Serenyi; E Dahl; J Grosse; R Knüchel
Journal:  Pathologe       Date:  2008-09       Impact factor: 1.011

3.  Seminal Vesicle Involvement by Carcinoma In Situ of the Bladder: Clonal Analysis Using Next-Generation Sequencing to Elucidate the Mechanism of Tumor Spread.

Authors:  Hyun Sik Park; Hyun Bin Shin; Myung-Shin Lee; Joo Heon Kim; Seon-Young Kim; Jinsung Park
Journal:  Cancer Res Treat       Date:  2020-03-19       Impact factor: 4.679

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.